ST Pharm
ST Pharm
01
Who we are
02
Our record
03
Newsroom
04
Contact
En
Ko
ST Pharm
Science & Technology
Business Overview
CDMO
Small Molecule
Oligonucleotide
mRNA
CRO
AnaPath Research & Service
R&D
Virtual R&D
Global R&D
About
ST PHARM
Key Members
History
Global Approval
ST Pharm Family
CI
Public
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
Careers
ESG
Overview
Environmental
Social
Governance
Sitemap
Contact
Linkedin
Public
Media Focus
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
ST PHARM's Public Release
All
Media Focus
ST PHARM News
Media Focus
ST PHARM Cuts Joint Research Deal with Multiverse Pharma in the U.S.
Feb 24, 2023
Media Focus
ST PHARM, signs $9.2million contract to supply MRI contrast medium raw materials
Jan 11, 2023
Media Focus
ST PHARM, Top 10 CDMOs In APAC 2022
Sep 26, 2022
Media Focus
ST PHARM Present Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022
Aug 4, 2022
Media Focus
ST PHARM Scores FDA's cGMP Certification (NAI) for Oligo Plant
Aug 2, 2022
Media Focus
ST PHARM's Banwol Campus 'Oligo Manufacturing Plants' cGMP Certified by USA FDA
Aug 1, 2022
Media Focus
ST PHARM's Cutting-edge Technology to Reduce the Cost of Promising Drug
Jul 28, 2022
Media Focus
ST PHARM to Supply Lipids to Biotech in North America
May 4, 2022
Media Focus
Korean drugmakers team up with CEPI to become global vaccine suppliers
Dec 27, 2021
Media Focus
ST Pharm receives presidential award for improving labor-management relations
Dec 1, 2021
Media Focus
Korea-based ST Pharm takes leap towards world's largest oligonucleotide CDMO
Nov 30, 2021
Media Focus
Korean companies eyeing mRNA vaccines to treat cancer
Aug 17, 2021
Media Focus
Korea launches mRNA vaccine consortium
Jun 29, 2021
1
of
2